Article

Macrophage-derived granulin drives resistance to immune checkpoint inhibition in…

medRxiv · 2017 · Quaranta, V.; Rainer, C.; Nielsen, S. R.; Raymant, M.; Ahmed, M. S.; Engle, D.; Taylor, A.; Murray, T.; Campbell, F.; Palmer, D.; Tuveson, D.; Mielgo, A.; Schmid, M.

Key facts

Title Macrophage-derived granulin drives resistance to immune checkpoint inhibition in metastatic pancreatic cancer
First author Quaranta, V.; Rainer, C.; Nielsen, S. R.; Raymant, M.; Ahmed, M. S.; Engle, D.; Taylor, A.; Murray, T.; Campbell, F.; Palmer, D.; Tuveson, D.; Mielgo, A.; Schmid, M.
Journal medRxiv
Published Dec 15, 2017
DOI 10.1101/234906
Devices mentioned BK110039, K912666
Product codes mentioned GIA, JJH, KIP, KIT, MVU, NDS, LIQ, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature